July 23 (Reuters) - Futures for Canada's main stock index pointed to a higher open on Monday as signs of progress in developing a COVID-19 vaccine renewed hopes for a post-pandemic economic rebound.
September futures on the S&P/TSX index SXFc1 were up 0.6% at 7:00 a.m. ET.
British drugmaker AstraZeneca AZN.L said over the weekend it had resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs. Toronto Stock Exchange's S&P/TSX composite index .GSPTSE ended 0.22% higher at 16,222.46 on Friday.
Dow Jones Industrial Average e-mini futures 1YMc1 were up 0.86% at 7:15 a.m. ET, while S&P 500 e-mini futures ESc1 were up 1.20% and Nasdaq 100 e-mini futures NQc1 were up 1.6%. .N
TOP STORIES TOP/CAN
Canadian private security company Garda World Security GRWSC.UL said on Monday it offered to buy British rival G4S (CSE:G4S) GFS.L for about 2.95 billion pounds ($3.80 billion), seeking to turnaround the London-listed firm. prices slipped slightly on Monday amid concerns about a stalled global economic recovery and worries over renewed Libyan supply, but were supported by an impending storm which has disrupted U.S. oil production. prices rose on Monday helped by a weaker dollar and expectations that the U.S. Federal Reserve will reiterate its dovish monetary policy stance this week. AT 7:00 a.m. ET
Gold futures GCc2 : $1,942; +0.13% GOL/
US crude CLc1 : $37.22; -0.29% O/R
Brent crude LCOc1 : $39.74; -0.23% O/R
FOR CANADIAN MARKETS NEWS, CLICK ON CODES:
TSX market report .TO
Canadian dollar and bonds report CAD/ CA/
Reuters global stocks poll for Canada EQUITYPOLL1 EPOLL/CA
Canadian markets directory CANADA ($1=C$1.32)